In vitro test system for predicting patient tolerability of therapeutic agents

Details for Australian Patent Application No. 2005227263 (hide)

International Classifications

Event Publications

21 September 2006 PCT application entered the National Phase

PCT publication WO2005/091956 Priority application(s): WO2005/091956

26 June 2008 Assignment before Grant

Chiron Corporation The application has been assigned to Novartis Vaccines and Diagnostics, Inc.

5 November 2009 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.